Atlas FDA

Vascade MVP VVCS

FDA premarket approval P120016/S027 · decided 2019-09-18

Approval details

PMA number
P120016
Supplement
S027
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Vascade MVP VVCS
Generic name
Device, hemostasis, vascular
Applicant
Cardiva Medical, Inc.
Date received
2019-07-08
Decision date
2019-09-18
Days to decision
72 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Clara, CA
Statement
Approval for modifying the braid design and related device components.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CATALYST II AND III (K130124)Cardiva Medical, Inc.2013-03-14
CARDIVA CATALYST III SYSTEM WITH PROTAMINE SULFATE (K082930)Cardiva Medical, Inc.2009-02-13
BOOMERANG CATALYST/BOOMERANG CATALYST II SYSTEM (K072297)Cardiva Medical, Inc.2007-09-12
BOOMERANG WIRE /BOOMERANG PLUS WIRE SYSTEM, MODEL# B PLUS WIRE 58L (K070485)Cardiva Medical, Inc.2007-03-22
BOOMERANG CLOSUREWIRE VASCULAR CLOSURE SYSTEM (K051817)Cardiva Medical, Inc.2006-12-06
BOOMERANG WIRE (K061075)Cardiva Medical, Inc.2006-09-01
VASOSTASIS VASCULAR CLOSURE SYSTEM (K041486)Cardiva Medical, Inc.2004-10-22